EUVIMEDOntdek EUVIMED
Systematische ÜbersichtMetaanalyseOpen access

Effects of Immersive Virtual Reality Interventions on Symptom Management in Patients With Gastrointestinal Cancer: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Fangping Chen, Xingyue Guo, Ran Wang, Yan Li, Didi Xu, Yongzhen Wang, Wei Kong, Yin Chen, Luyang Jin, Xuemei Xian

Journal of Medical Internet Research · 2026-07-02 · 28 · e86808-e86808

DOI: 10.2196/86808 ↗

At a glance

Systematische Übersicht in Journal of Medical Internet Research, published online on 2026-07-02. Written by Fangping Chen and 9 co-authors. Institution: Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 Qingchun East Road, Hangzhou, Zhejiang, 3610016, China, 86 1…. Major MEDLINE topics: Gastrointestinal Neoplasms, Virtual Reality. 64 references. The full text is freely available in PubMed Central.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Background

Patients with gastrointestinal cancers experience a broad range of symptoms, including anxiety, pain, and reduced quality of life. Although immersive virtual reality (IVR) has emerged as a potential intervention, its efficacy specifically in patients with gastrointestinal cancer remains unclear.

Objective

This systematic review and meta-analysis of randomized controlled trials (RCTs) evaluated the effects of IVR on symptom management in patients with gastrointestinal cancer.

Methods

Twelve databases and 1 gray literature source were searched from inception to April 30, 2026. RCTs comparing IVR interventions to routine care or nonimmersive alternatives for symptom management in adults (≥18 years) with gastrointestinal cancer were eligible. Two reviewers independently screened records, extracted data, and assessed risk of bias using the Cochrane RoB 2 tool. The evidence certainty was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Random-effects meta-analyses were performed for primary outcomes (anxiety, pain, quality of life) and secondary outcomes (knowledge, length of stay, vital signs, safety). Heterogeneity was explored using subgroup analyses and meta-regression.

Results

Fourteen RCTs were included, comprising individuals (N=837) with colorectal, liver, esophageal, gastric, pancreatic, and biliary tract cancers. IVR interventions—including immersive scenes, interactive games, anatomical models, and cognitive behavioral modules—were primarily delivered during perioperative and chemotherapy periods. Meta-analysis showed that IVR significantly reduced anxiety (standardized mean difference [SMD] −0.58, 95% CI −0.95 to −0.20; P =.01; 95% prediction interval [PI] −1.36 to 0.21) and pain (SMD −0.75, 95% CI −1.48 to −0.03; P =.04; 95% PI −2.21 to 0.71). Subgroup analysis revealed that the anxiolytic effect was more pronounced when IVR was administered during active treatment and when single sessions lasted ≥20 minutes. Hospital stay was significantly shorter in the IVR group (mean difference −4.11 days, 95% CI −7.39 to −0.82; P =.03; 95% PI −13.82 to 5.60 days). No significant effects were detected for quality of life, knowledge acquisition, or vital signs. The evidence certainty was moderate to very low, with common limitations including risk of bias and imprecision.

Conclusions

This meta-analysis provides evidence that IVR is an effective nonpharmacological adjunct for symptom management in patients with gastrointestinal cancer, significantly reducing anxiety and pain when implemented during active treatment for at least 20 minutes. However, these findings should be interpreted with caution due to moderate to high heterogeneity, substantial risk of bias in the included studies, and low to very low GRADE evidence certainty. While the 95% CIs indicate a statistically significant average effect, the wide 95% PIs suggest that the true effect in future clinical settings may vary considerably, ranging from marked benefit to negligible impact. These results support the integration of IVR into perioperative and chemotherapy care pathways while underscoring the need for larger, more rigorously designed trials to establish definitive conclusions.

Subjects

MeSH terms (MEDLINE)

Gastrointestinal NeoplasmsVirtual RealityHumansRandomized Controlled Trials as TopicQuality of LifeAnxiety

Author keywords

gastrointestinal cancermeta-analysisnonpharmacological adjunctsymptom managementsystematic reviewvirtual reality

Authors and institutions

  • Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 Qingchun East Road, Hangzhou, Zhejiang, 3610016, China, 86 13867406749, 86 0571-86044817.
  • Nursing Department, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China.

Cite

APA

Chen, F., Guo, X., Wang, R., Li, Y., Xu, D., Wang, Y., Kong, W., Chen, Y., Jin, L., & Xian, X. (2026). Effects of Immersive Virtual Reality Interventions on Symptom Management in Patients With Gastrointestinal Cancer: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Medical Internet Research, 28, e86808-e86808. https://doi.org/10.2196/86808

Vancouver

Chen F, Guo X, Wang R, Li Y, Xu D, Wang Y, et al. Effects of Immersive Virtual Reality Interventions on Symptom Management in Patients With Gastrointestinal Cancer: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Medical Internet Research. 2026;28:e86808-e86808. doi:10.2196/86808

BibTeX
@article{Chen2026,
  author = {Chen, Fangping and Guo, Xingyue and Wang, Ran and Li, Yan and Xu, Didi and Wang, Yongzhen and Kong, Wei and Chen, Yin and Jin, Luyang and Xian, Xuemei},
  title = {Effects of Immersive Virtual Reality Interventions on Symptom Management in Patients With Gastrointestinal Cancer: Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e86808--e86808},
  doi = {10.2196/86808}
}
Start for free →